- Home
- HAIN vs ZVRA Comparison
HAIN vs ZVRA Comparison
Compare HAIN & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAIN
- ZVRA
- Stock Information
- Founded
- HAIN 1993
- ZVRA 2006
- Country
- HAIN United States
- ZVRA United States
- Employees
- HAIN N/A
- ZVRA N/A
- Industry
- HAIN Packaged Foods
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- HAIN Consumer Staples
- ZVRA Health Care
- Exchange
- HAIN Nasdaq
- ZVRA Nasdaq
- Market Cap
- HAIN 445.6M
- ZVRA 419.5M
- IPO Year
- HAIN 1993
- ZVRA 2015
- Fundamental
- Price
- HAIN $4.18
- ZVRA $7.69
- Analyst Decision
- HAIN Hold
- ZVRA Strong Buy
- Analyst Count
- HAIN 8
- ZVRA 7
- Target Price
- HAIN $6.56
- ZVRA $21.20
- AVG Volume (30 Days)
- HAIN 2.0M
- ZVRA 380.4K
- Earning Date
- HAIN 02-10-2025
- ZVRA 03-27-2025
- Dividend Yield
- HAIN N/A
- ZVRA N/A
- EPS Growth
- HAIN N/A
- ZVRA N/A
- EPS
- HAIN N/A
- ZVRA N/A
- Revenue
- HAIN $1,663,238,000.00
- ZVRA $24,489,000.00
- Revenue This Year
- HAIN N/A
- ZVRA N/A
- Revenue Next Year
- HAIN $2.22
- ZVRA $330.04
- P/E Ratio
- HAIN N/A
- ZVRA N/A
- Revenue Growth
- HAIN N/A
- ZVRA 47.85
- 52 Week Low
- HAIN $3.28
- ZVRA $4.20
- 52 Week High
- HAIN $10.07
- ZVRA $9.76
- Technical
- Relative Strength Index (RSI)
- HAIN 36.49
- ZVRA 48.77
- Support Level
- HAIN $3.87
- ZVRA $7.64
- Resistance Level
- HAIN $4.60
- ZVRA $8.21
- Average True Range (ATR)
- HAIN 0.37
- ZVRA 0.29
- MACD
- HAIN 0.00
- ZVRA 0.03
- Stochastic Oscillator
- HAIN 50.28
- ZVRA 57.93
About HAIN Hain Celestial Group Inc. (The)
The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas among others. It operates under two reportable segments; North America and International. The majority of its revenue is derived from the North America segment which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.